Ligand-activated PPARβ/δ could promote terminal differentiation of keratinocytes [129], enhance lipid deposition [130], inhibit cell proliferation [131], and inhibit the progression of skin cancers such as psoriasis. This evidence concerns the gene PPARD and skin neoplasm.